Therapeutic Approaches to Activating Programmed Cell Death of Androgen-Independent Prostatic Cancer Cells
- 1 January 1991
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- “Thymineless” death in androgen-independent prostatic cancer cellsBiochemical and Biophysical Research Communications, 1989
- Calcium channel antagonists delay regression of androgen‐dependent tissues and suppress gene activity associated with cell deathThe Prostate, 1988
- Activation of a Ca2+−Mg2+‐dependent endonuclease as an early event in castration‐induced prostatic cell deathThe Prostate, 1988
- Effect of adrenalectomy, flutamide, and leuprolide on the growth of the dunning rat R-3327 prostatic carcinomaThe Prostate, 1988
- Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes.Journal of Clinical Investigation, 1985
- Probabilities of Eventually Developing or Dying of Cancer--United States, 1985CA: A Cancer Journal for Clinicians, 1985
- Investigation of the combination of the agonist D-Trp-6-LH-RH and the antiandrogen flutamide in the treatment of dunning R-3327H prostate cancer modelThe Prostate, 1985
- The timing of androgen ablation therapy and/or chemotherapy in the treatment of prostatic cancerThe Prostate, 1984
- Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activationNature, 1980
- Autoradiographische Untersuchungen an inkubierten Prostatapunktaten nach Doppelmarkierung mit C-14- und H-3-ThymidinBeiträge zur Pathologie, 1974